UVEAL MELANOMA
Clinical trials for UVEAL MELANOMA explained in plain language.
Never miss a new study
Get alerted when new UVEAL MELANOMA trials appear
Sign up with your email to follow new studies for UVEAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radioactive antibody targets Hard-to-Treat cancers
Disease control TerminatedThis early-phase study tested a radioactive drug designed to seek out and destroy cancer cells in people with advanced solid tumours (like breast, ovarian, or head and neck cancers) that had stopped responding to standard treatments. The drug uses a radioactive particle attached …
Matched conditions: UVEAL MELANOMA
Phase: PHASE1 • Sponsor: Fusion Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 22, 2026 11:59 UTC
-
New combo therapy for eye cancer shows promise in early trial
Disease control TerminatedThis study tested a combination of targeted radiation and an injection medication (aflibercept) for people with a rare eye cancer called uveal melanoma. The goal was to see if this approach could control the tumor while reducing damage to healthy eye tissue. Only 3 people took pa…
Matched conditions: UVEAL MELANOMA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 11, 2026 12:11 UTC
-
Experimental drug fails to gain traction in rare eye cancer trial
Disease control TerminatedThis study tested a targeted therapy called BVD-523 in 13 people with advanced uveal melanoma, a rare eye cancer that had spread. The goal was to see if the drug could shrink tumors or control the disease. The trial was stopped early, and results were limited.
Matched conditions: UVEAL MELANOMA
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 29, 2026 14:17 UTC